Overview
4th Annual Advancements in Cancer Management
Registration is closed for this activity.
Advancements in Cancer Management is an educational forum designed to foster dialogue between primary care providers (PCPs) and the oncology team and to provide strategies that contribute to integrative cancer care for patients. Panel discussions, case studies, and question-and-answer sessions will take place to enhance clinician knowledge and competence. Topics such as screening high-risk patients, cancer pain management, immunotherapy treatment and adverse event management, monitoring for the long-term effects of treatment and/or disease, combining integrative therapies with cancer treatment, and drug-drug interactions will be covered for PCPs to expand their knowledge and transform their practices in cancer care.
Advancements in Cancer Management is designed to meet the educational needs of primary care providers and specialists involved in the care of patients with cancer.
Upon completion of this activity, participants will be able to:
- Explain the use of multimodal analgesia to manage pain and reduce the use of opioids.
- Describe how integrative therapies and lifestyle change programs are employed as adjunct therapies in the care of cancer patients.
- Evaluate immuno-oncology approaches in cancer treatment, including patient selection.
- Describe the appropriate follow-up protocols for identification of pulmonary nodules.
- Recognize the pathophysiology and clinical presentations of various subtypes of pleural effusions.
- Describe the various treatment options for each of the various pleural effusions.
Gene And Georgetti Rosemont
9421 W Higgins Rd
Rosemont, IL 60018 USA
Click here to view location map
Phone: 847-653-3300
9421 W Higgins Rd
Rosemont, IL 60018 USA
Click here to view location map
Phone: 847-653-3300
7:00 AM CHECK-IN, ON-SITE REGISTRATION AND BREAKFAST
7:30 AM Welcome, Introductions & Setting the Stage
Kevin Tulipana, DO, FHM, Cancer Treatment Centers of America, Tulsa, OK
7:40 AM Updates in Immuno-Oncology in 2018: Is the Checkpoint a Checkmate?
Ankur Parikh, DO, Cancer Treatment Centers of America, Philadelphia, PA
8:25 AM Challenges of Managing Cancer Pain
Vivek Iyer, MD, Cancer Treatment Centers of America, Phoenix, AZ
9:10 AM Integrative Oncology: What Is It and Can It Help Your Patients?
Lorenzo Cohen, PhD, MD Anderson Cancer Center, Houston, TX
9:55 AM BREAK
10:05 AM How to Deal with a Radiology “Hedge”
Kenny Yoo, MD, Cancer Treatment Centers of America, Chicago, IL
10:50 AM Diagnositic Approaches to Pleural Effusions
Larry Ladi, MD, FCCP, Cancer Treatment Centers of America, Tulsa, OK
11:35 AM Expert Opinions Panel
All Faculty
11:50 AM Wrap-up
Stephen Lynch, MD, Cancer Treatment Centers of America, Phoenix, AZ
12:00 PM MEETING ADJOURNMENT
7:30 AM Welcome, Introductions & Setting the Stage
Kevin Tulipana, DO, FHM, Cancer Treatment Centers of America, Tulsa, OK
7:40 AM Updates in Immuno-Oncology in 2018: Is the Checkpoint a Checkmate?
Ankur Parikh, DO, Cancer Treatment Centers of America, Philadelphia, PA
8:25 AM Challenges of Managing Cancer Pain
Vivek Iyer, MD, Cancer Treatment Centers of America, Phoenix, AZ
9:10 AM Integrative Oncology: What Is It and Can It Help Your Patients?
Lorenzo Cohen, PhD, MD Anderson Cancer Center, Houston, TX
9:55 AM BREAK
10:05 AM How to Deal with a Radiology “Hedge”
Kenny Yoo, MD, Cancer Treatment Centers of America, Chicago, IL
10:50 AM Diagnositic Approaches to Pleural Effusions
Larry Ladi, MD, FCCP, Cancer Treatment Centers of America, Tulsa, OK
11:35 AM Expert Opinions Panel
All Faculty
11:50 AM Wrap-up
Stephen Lynch, MD, Cancer Treatment Centers of America, Phoenix, AZ
12:00 PM MEETING ADJOURNMENT
Kevin Tulipana, DO, FHM (Chair)
Director of Hospital Medicine
Vice Chief of Staff
Cancer Treatment Centers of America
Tulsa, OK
Director of Hospital Medicine
Vice Chief of Staff
Cancer Treatment Centers of America
Tulsa, OK
Stephen Lynch, MD (Co-Chair)
Primary Care/Intake Physician
Vice Chief of Staff
Vice Chief of Staff
Cancer Treatment Centers of America
Goodyear, AZ
Lorenzo Cohen, PhD (Faculty)
Richard E. Haynes Distinguished Professor
in Clinical Cancer Prevention
Director of Integrative Medicine
University of Texas MD Anderson Cancer Center
Houston, TX
Vivek Iyer, MD
Medical Director of Pain Management; Interventional Pain Management Specialist
Cancer Treatment Centers of America Phoenix, AZ
Vivek Iyer, MD
Medical Director of Pain Management; Interventional Pain Management Specialist
Cancer Treatment Centers of America Phoenix, AZ
Larry Ladi, MD, FCCP (Faculty)
Intensivist
Cancer Treatment Centers of America
Tulsa, OK
Ankur Parikh, DO (Faculty)
Medical Director, Precision Medicine
Hematologist/Medical Oncologist
Cancer Treatment Centers of America
Philadelphia, PA
Kenny Yoo, MD (Faculty)
Interventional Radiologist
Cancer Treatment Centers of America
Chicago, IL
Kenny Yoo, MD (Faculty)
Interventional Radiologist
Cancer Treatment Centers of America
Chicago, IL
The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME activity.
Discussion of off-label, investigational or experimental drug use: None
The following financial relationships have been provided:
Vivek Iyer, MD (Faculty)
Consultant (Occasional)- Avanos Medical
Lorenzo Cohen, PhD (Faculty)
Consultant for research- Cancer Treatment Centers of America
The following faculty have no relevant financial relationships to disclose:
Vivek Iyer, MD (Faculty)
Consultant (Occasional)- Avanos Medical
Lorenzo Cohen, PhD (Faculty)
Consultant for research- Cancer Treatment Centers of America
The following faculty have no relevant financial relationships to disclose:
Kevin Tulipana, DO, FHM (Chair)
Stephen Lynch, MD (Co-Chair)
Larry Ladi, MD, FCCP (Faculty)
Ankur Parikh, DO (Faculty)
Kenny Yoo, MD (Faculty)
Stephen Lynch, MD (Co-Chair)
Larry Ladi, MD, FCCP (Faculty)
Ankur Parikh, DO (Faculty)
Kenny Yoo, MD (Faculty)
Discussion of off-label, investigational or experimental drug use: None
ACHL and CTCA staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.
The content for this activity was developed independently. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher.
This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.
This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.
To receive credit, participants are required to participate in the live activity, complete the evaluation and submit on-site. A certificate will be emailed to participants within 6 weeks. Please be sure to check your junk/spam folders. Due to firewalls, the certificate emails sometimes go there. There is no fee to participate in the activity or for the generation of the certificate.
Inquiries may be directed to ACHL at (877) 444-8435, ext. 160.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL), the Osteopathic Founders Foundation (OFF) and Cancer Treatment Centers of America (CTCA). ACHL is accredited by the ACCME to provide continuing medical education for physicians. The Osteopathic Founders Foundation is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Osteopathic Founders Foundation is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. The Osteopathic Founders Foundation designates this program for a maximum of 4.25 AOA Category 1-A credits. OFF will report CME and specialty credits commensurate with the extent of the osteopathic physician’s participation in this activity.
MOC Part II
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Maintenance of Certification (“MOC”) Activities through the ABMS Continuing Certification Directory, 4th Annual Advancements in Cancer Management (Tulsa, OK) has met the requirements as an MOC Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:
MOC Part II CME Activity
Anesthesiology
Family Medicine
Medical Genetics and Genomics
Physical Medicine and Rehabilitation
Preventive Medicine
Psychiatry & Neurology
Radiology